The 2025 Sperm DNA Fragmentation Guidelines, Translated for Couples

Evidence-based · Written by Dr. Lejla Fazlicic, D.Ac, L.Ac · All key claims cited to peer-reviewed research · Last reviewed October 2026

The short answer: In 2025, 52 experts from the Global Andrology Forum published the first comprehensive sperm DNA fragmentation guidelines — 24 evidence-graded statements on when this test actually matters: recurrent pregnancy loss, failed IVF or ICSI cycles, and varicocele, rather than as a routine test for everyone. And when levels come back high, the same expert network recommends starting with months of lifestyle-based conservative management — not jumping straight to more procedures. This article translates what that means for your next cycle.

If you are reading this at 2 a.m. after a failed cycle or another loss, holding a lab report with an unfamiliar acronym on it, I want you to know two things before we go any further. First: nothing in the sperm DNA fragmentation guidelines assigns blame to anyone — DNA fragmentation is heavily driven by things like oxidative stress, and much of it is often modifiable. Second: I am not your doctor, and this is not medical advice. What I can do — what this entire article does — is translate a dense, clinician-facing consensus document into plain language, so that when you sit down with your urologist or reproductive endocrinologist, you are reading from the same page they are. The full guideline is open access, and I will link it so you can bring it with you.

What do the new sperm DNA fragmentation guidelines say?

In 2025, the Global Andrology Forum — a multidisciplinary network of researchers and clinicians in male reproductive health — published its Clinical Guidelines on the Relevance of Sperm DNA Fragmentation in Reproductive Medicine in the World Journal of Men's Health. Fifty-two experts took part. Using a modified Delphi process (a structured method for reaching expert consensus) and the GRADE system for rating the strength of evidence, they produced 24 evidence-based statements. Of those, 87.5% — 21 of the 24 — were rated strong, and 12.5% (3 of 24) were rated weak.

The guideline addresses the role of sperm DNA fragmentation (SDF) across the situations couples actually face: male infertility management, recurrent pregnancy loss, varicocele, and assisted reproduction (IVF and ICSI) outcomes. It also covers the practical layer underneath — testing methods and indications, antioxidant therapy, and sperm selection strategies for ART.

Here is the part I most want you to hear, because it cuts both ways. The panel emphasizes tailored, scenario-based use of the test. The authors state that clinicians must "balance the benefits and limitations of SDF testing," and they are explicit that "significant gaps in the literature limit its routine use in clinical practice." In other words: this is not a test the world's top andrology panel thinks every man should get. It is a test they think matters a great deal in specific, definable situations — and the guideline's job is to define them.

One honest caveat about this article: I am summarizing the guideline's published scope and framing, not paraphrasing all 24 statements one by one. The exact wording of each statement — and the evidence grade attached to it — lives in the open-access paper itself. If a specific statement will shape a decision you are making, read it in the original, and read it with your clinician.

What is sperm DNA fragmentation, and why did it need a guideline?

A standard semen analysis counts sperm, watches how they move, and looks at their shape. It says nothing about the integrity of the DNA those sperm carry. Sperm DNA fragmentation refers to breaks in that genetic material — single- or double-strand breaks that can accumulate before or after ejaculation. A man can have a completely normal semen analysis and still have a high proportion of sperm with fragmented DNA, which is one reason couples with a "normal" semen analysis and a failed cycle so often feel like they are missing a piece of the puzzle. The test result is usually reported as a DNA fragmentation index (DFI): the percentage of sperm with detectable DNA damage.

Why does it matter? The research linking SDF to outcomes has been accumulating for two decades. A 2017 meta-analysis by Simon and colleagues pooled 56 studies covering 8,068 IVF and ICSI treatment cycles and found that sperm DNA damage was associated with significantly lower odds of clinical pregnancy — a combined odds ratio of 1.68 (95% CI 1.49–1.89) in favor of the low-damage groups. On the loss side, a 2012 meta-analysis by Robinson and colleagues, covering 2,969 couples across 16 studies, found miscarriage rates roughly doubled in patients with high sperm DNA damage compared with low (risk ratio 2.16; 95% CI 1.54–3.03).

Two crucial translation notes on those numbers. First, these are associations across groups — they shift probabilities; they do not decide any single couple's outcome. Plenty of pregnancies happen despite elevated DFI. Second, the underlying biology carries a genuinely hopeful message. A major review in Nature Reviews Urology concluded that "DNA damage, largely owing to oxidative stress, is a leading cause of defective sperm function" — and that oxidative stress is predominantly driven by lifestyle-related factors, most of which are modifiable. Fragmentation is not, for most men, a fixed trait. It is a snapshot, and snapshots can change.

So why did this need a guideline? Because for years the field ran on conflicting advice — some clinics tested everyone, others tested no one — and couples were caught in the middle, often paying out of pocket for a test nobody could quite tell them how to act on. A 52-expert consensus with graded evidence attached to each statement is the field's attempt to end that whiplash.

When do the guidelines say testing makes sense?

The 2025 guideline is organized around scenarios, and its scope tells you exactly which scenarios the panel considered worth addressing: male infertility management, recurrent pregnancy loss, varicocele, and IVF/ICSI outcomes — along with testing indications, antioxidant therapy, and sperm selection for ART. This scenario-based logic is not new; it builds on earlier practice recommendations (Agarwal and colleagues, 2016) that mapped SDF testing to situations like clinical varicocele with borderline-to-normal semen parameters, recurrent pregnancy loss, and recurrent IVF failure. What 2025 adds is scale, multidisciplinary breadth, and formal evidence grading.

Here is the practical translation, situation by situation. The middle column reflects the guideline's scope and the broader consensus literature; the right column is mine — the questions I would want a couple to have in hand.

If you are weighing whether to get tested, it helps to know the logistics too — I have written a separate plain-language guide to what the SDF test costs and how to read the results, including the different assay types, since labs do not all measure fragmentation the same way.

How does this differ from the AUA/ASRM position?

Here is where couples get understandably confused, so let's untangle it. The American Urological Association and the American Society for Reproductive Medicine, in their joint guideline on the diagnosis and treatment of infertility in men (published 2020, amended 2024), state plainly: "Clinicians should not recommend sperm deoxyribonucleic acid (DNA) fragmentation analysis in the initial evaluation of the infertile couple" (Guideline Statement 16, a moderate recommendation based on Grade C evidence). Read quickly, that can sound like American urology has dismissed the test entirely.

It hasn't — and the key phrase is initial evaluation. The AUA/ASRM position is about not testing everyone at the front door. The 2025 Global Andrology Forum guideline, for its part, openly concedes that "significant gaps in the literature limit its routine use in clinical practice." On the question of routine screening, the two documents actually agree: no.

Where the 2025 guideline moves the conversation forward is everything after the front door. Rather than stopping at "not routine," it maps the specific scenarios — recurrent pregnancy loss, ART failure, varicocele — where testing may earn its place, and grades the evidence behind each statement. So the honest summary is not "one guideline says yes and one says no." It is: don't test reflexively; testing may be considered in defined situations, when a urologist or reproductive endocrinologist thinks the result would change the plan. The newest guideline, NICE (2026), goes further and advises against testing sperm DNA integrity at all. That convergence — skepticism about routine use, seriousness about targeted use — is arguably the most reassuring thing about the current guidance: the field is being careful with your money and your hope at the same time.

What do experts recommend when DFI is high?

Suppose you have tested, and the number is elevated. This is the moment couples most often feel pushed toward escalation, so it is worth knowing what the Global Andrology Forum's own management consensus (Farkouh and colleagues, 2023 — a global survey of 436 experts paired with evidence review, in which 8 of the 10 management recommendations passed with over 80% consensus) actually recommends first.

First-line is lifestyle-based, conservative management. The consensus recommends lifestyle modification as the starting point: cessation of smoking and alcohol use, and treating genital infections where present. None of this is glamorous, and none of it is blame — it is simply where the modifiable causes of oxidative stress live, and oxidative stress is a leading driver of sperm DNA damage.

Shorter abstinence, specifically. One concrete, zero-cost recommendation: reduced ejaculatory abstinence of 12–24 hours before attempting conception — natural or through ART — as a means to lower SDF. This surprises many couples, who have often been told to "save up." Sperm that sit longer in the reproductive tract have more time to accumulate oxidative damage; fresher is, by this logic, better. (Confirm the exact timing with your clinic, especially around a scheduled retrieval.)

Antioxidants are widely used — with honest uncertainty. In the global survey, 76.9% of the 436 experts prescribe empiric antioxidants for elevated SDF. On duration, 39.3% recommend 4–6 months and 38.1% recommend 3 months — so the field's working window is roughly three to six months. I want to be careful here: "most experts prescribe this" is a statement about practice patterns, not proof of benefit, and the 2025 guideline addresses antioxidant therapy precisely because the evidence needs sorting. Which supplement, what dose, and whether it is appropriate for you are questions for your physician, not a blog.

Varicocele repair is a case-by-case call. For men with a clinical varicocele, normal conventional semen parameters, and elevated SDF, 31.4% of surveyed experts offer repair immediately after diagnosis, while 40.9% offer it after antioxidants and conservative measures have failed. That split is worth seeing clearly: it means reasonable specialists sequence this differently, and it is fair to ask yours why they prefer the order they do.

ART is not the first move. The consensus states that ART methods are "not recommended as first-line treatment strategies" for elevated SDF, with most experts referring to ART around six months after conservative and empiric management has failed. When ART is the right path — and for many couples it is — sperm selection techniques and testicular sperm extraction (retrieving sperm directly from the testis, where DNA damage tends to be lower) are options that belong to that stage, not before it. If you are in the aftermath of a failed transfer, my deeper dive on sperm DNA fragmentation and IVF failure walks through how clinics think about that decision.

What does this mean for your next cycle?

Let me translate all of this into a timeline, because that is what you are actually planning around.

Sperm are produced on a cycle of roughly two and a half months, which is why the expert-recommended antioxidant windows run three to six months and why retesting too early tells you almost nothing. If you make changes today — quitting smoking, cutting alcohol, treating an infection, adjusting abstinence timing — the ejaculate that reflects those changes is months away, not weeks. I've covered the daily side in daily habits linked to sperm DNA health in the 74 days before IVF. The planning point is simple: the months of lifestyle-based management that experts recommend are not "doing nothing". They are time the sperm for the next cycle are being made, and his urologist and clinic decide what comes next.

For a couple planning a next cycle, the guidance suggests a conversation with your urologist or RE structured around four questions. One: does our history — losses, failed cycles, varicocele — put us in a scenario where the 2025 guideline says SDF information could change management? Two: if we test and it is elevated, what is our specific conservative plan, and for how long? Three: what would trigger escalation — varicocele repair, sperm selection, testicular sperm — and at what point? Four: how will we know it worked; when do we retest? Bring the open-access guideline with you — a good clinician will be glad you are reasoning from the same document.

And one gentle reframe, because I know how heavy this topic can feel at 2 a.m.: an elevated DFI is one of the few findings where experts start with things your household can do: not smoking, cutting alcohol, shorter abstinence. Nothing guarantees the number will change. But it gives him something real to do while his urologist and clinic guide testing and treatment.

What we do with this

At Cycle Decoded, this is the kind of translation we do: turning the guidelines your clinical team reads into plain language and good questions to bring to them. Every medical decision stays with your urologist or reproductive endocrinologist. If you want help with the part that happens at home, the daily habits for both of you in the months before IVF, start with the free guide: Get the free guide →. And if you would rather talk it through with a human first, that is what my calendar is for: Try Pocket Coach for him free for 7 days →.

References

1. Global Andrology Forum. Clinical Guidelines on the Relevance of Sperm DNA Fragmentation in Reproductive Medicine. World Journal of Men's Health. 2025. doi:10.5534/wjmh.250005. Open access: https://wjmh.org/DOIx.php?id=10.5534%2Fwjmh.250005 (PubMed: 40263962).
2. Farkouh A, Agarwal A, Hamoda TAAAM, et al.; Global Andrology Forum. Controversy and Consensus on the Management of Elevated Sperm DNA Fragmentation in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. World Journal of Men's Health. 2023;41(4):809–847. doi:10.5534/wjmh.230008. https://pmc.ncbi.nlm.nih.gov/articles/PMC10523126/
3. American Urological Association / American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; amended 2024). https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility
4. Simon L, Zini A, Dyachenko A, Ciampi A, Carrell DT. A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome. Asian Journal of Andrology. 2017;19(1):80–90. doi:10.4103/1008-682X.182822. https://journals.lww.com/ajandrology/fulltext/2017/19010/a_systematic_review_and_meta_analysis_to_determine.15.aspx
5. Robinson L, Gallos ID, Conner SJ, et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Human Reproduction. 2012;27(10):2908–2917. doi:10.1093/humrep/des261. https://academic.oup.com/humrep/article/27/10/2908/647321
6. Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nature Reviews Urology. 2017;14:470–485. doi:10.1038/nrurol.2017.69. https://www.nature.com/articles/nrurol.2017.69
7. Agarwal A, Majzoub A, Esteves SC, Ko E, Ramasamy R, Zini A. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Translational Andrology and Urology. 2016;5(6):935–950. doi:10.21037/tau.2016.10.03. https://pmc.ncbi.nlm.nih.gov/articles/PMC5182232/
8. Zini A, Boman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Human Reproduction. 2008;23(12):2663–2668. doi:10.1093/humrep/den321. https://academic.oup.com/humrep/article/23/12/2663/613426

Frequently Asked Questions

Should every man get a sperm DNA fragmentation test?

Based on current guidance, no. The 2025 Global Andrology Forum guideline states that significant gaps in the literature limit the test's routine use in clinical practice, and the AUA/ASRM guideline advises against SDF analysis in the initial evaluation of the infertile couple. Testing appears most useful in specific scenarios — such as recurrent pregnancy loss, failed IVF/ICSI cycles, or clinical varicocele — and the decision belongs with your urologist or reproductive endocrinologist.

How long does it take to lower sperm DNA fragmentation?

There is no guaranteed timeline, but expert practice patterns suggest a window of roughly three to six months: in the Global Andrology Forum survey, 39.3% of experts recommend 4–6 months of empiric antioxidants and 38.1% recommend 3 months, alongside first-line lifestyle changes such as smoking and alcohol cessation. Because sperm are produced over a cycle of about two and a half months, retesting before roughly three months may not reflect your changes. Your clinician can set a retest date suited to your situation.

Can you still get pregnant with high sperm DNA fragmentation?

Yes — an elevated result shifts probabilities; it does not determine any single couple's outcome. Meta-analyses associate high SDF with lower clinical pregnancy odds after IVF/ICSI and with higher miscarriage risk, but many couples conceive despite elevated levels. Expert consensus recommends starting with months of lifestyle-based management, so ask your clinician what an elevated result means for your plan.

This article is an educational translation of published guidelines, not medical advice; testing and treatment decisions belong with your urologist or reproductive endocrinologist.